BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2021 financial results before market opening on Friday, February 11, 2022. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to discuss the results and current business trends. To listen to the... Read more
WALTHAM, Mass., Feb. 2, 2022 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2021. Fourth Quarter and Full Year 2021 Highlights Fourth quarter revenue was $10.70 billion. Fourth quarter GAAP diluted earnings per share (EPS)... Read more
4Q Revenue of $1.36 billion; 1% reported growth; -9% organic growth 4Q GAAP EPS from continuing operations of $1.41; Adjusted EPS of $2.56 Initiates First Quarter and Full Year 2022 Guidance WALTHAM, Mass.–(BUSINESS WIRE)–Feb. 1, 2022– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for... Read more
MENLO PARK, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter and full year 2021 financial results on Tuesday, February 15, 2022, at 4:30 pm Eastern Time. The call will be webcast live and may be accessed at Pacific... Read more
RYE BROOK, N.Y.–(BUSINESS WIRE)–Jan. 31, 2022– Global water technology leader, Xylem (NYSE:XYL), today announced the appointment of Mark Morelli to the Company’s Board of Directors, effective February 3, 2022. Mr. Morelli currently serves as President and CEO of Vontier Corporation, the $3B global industrial technology company focused on smarter mobility. He brings nearly two decades... Read more
WASHINGTON, Jan. 27, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the fourth quarter and full year 2021. All results in this release reflect only continuing operations unless otherwise noted. For the quarter ended December 31, 2021, net earnings were $1.8 billion, or $2.39 per diluted common share which represents a... Read more
Record quarterly revenue of $764 million, up 16% year-over-year Record quarterly Non-GAAP net earnings of $168 million, up 29% year-over-year, and quarterly GAAP net income of $150 million, up 30% year-over-year Record annual revenue of $2.9 billion, up 27% year-over-year Record annual Non-GAAP net Read more
MENLO PARK, Calif., Jan. 14, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 80,000 shares of PacBio common stock, and restricted stock units (“RSUs”) covering 40,000 shares... Read more